TYBR HEALTH INC
Flowable bio-gel barrier that prevents post-surgical tissue tethering
- Sector
- Medtech
- Headquarters
- Houston, TX
- Founded
- 2020
- Latest Form D
- $1.1M, Jan 2025
- Total capital
- $3.4M
- Federal grants
- $1.6M
- 7 awards · 2021–2026
- Rank in peer group#2 of 35
- Private capital raised
- $1.8M
- 2 Form D · last Jan 2025
- 21 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Federal grantDefense · Phase I · B3 Hydrogel To Improve Prolonged Combat Casualty Care$75K
- Private capital raisedForm D · SEC · 2nd filing$1.1M
- Federal grantHealth and Human S · Phase I · Improving the safety and effectiveness of adhesion prevention following colorectal procedures with high risk of cancer or infection$270K
- Federal grantHealth and Human S · Phase I · Improving the safety and effectiveness of adhesion prevention following colorectal procedures with high risk of cancer or infection$270K
- Federal grantHealth and Human S · Phase I · Evaluation of extracellular matrix gel for adhesion prevention and tissue healing intendon surgery$257K
- Federal grantHealth and Human S · Phase I · Evaluation of extracellular matrix gel for adhesion prevention and tissue healing intendon surgery$257K
- Federal grantHealth and Human S · Phase I · Characterization of the Effect of an ECM Based Adhesion Barrier on Healing of Bowel Anastomoses$256K
- Private capital raisedForm D · SEC · 1st filing$710K
Show 1 earlier federal award
- Federal grantHealth and Human S · Phase I · Characterization of the Effect of an ECM Based Adhesion Barrier on Healing of Bowel Anastomoses$256K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 35 peers
Line = medianMedtech · Material
- Federal grants#2 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Timothy KeaneResearcherExecutive Officer, DirectorLinked by $526K in grants as PI
- Alex J. SmithDirectorNamed in SEC Form D filings
- Cooper J. CollinsDirectorNamed in SEC Form D filings
- Jeffrey J. TyberDirectorNamed in SEC Form D filings
- Stephen J. RamonExecutive OfficerNamed in SEC Form D filings
- Timothy J. Keane, Jr.Executive Officer, Director, PromoterNamed in SEC Form D filings
Show all 8 people
- Toby J. HamiltonDirectorNamed in SEC Form D filings
- Tom DuganDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingDevices And Methods For Delivery Of Multi-component FluidsUSPTOApplication 19181151
- PendingSystems And Methods For Delivery Of Multi-component FluidsUSPTOApplication 18324584
- PendingDevices And Methods For Delivery Of Multi-component FluidsUSPTOApplication PCTUS2025025013
Show all 4 patent records
- Devices And Methods For Delivery Of Multi-component FluidsJun 11, 2026 · Application 19181151Pending
- Systems And Methods For Delivery Of Multi-component FluidsNov 23, 2023 · Application 18324584Pending
- Devices And Methods For Delivery Of Multi-component FluidsApplication PCTUS2025025013Pending
- Devices And Methods For Delivery Of Multi-component FluidsApplication 63635366Pending
Related companies, and why
- SPACERX LLCSimilar federal contract value in Medtech · null in contracts
- INFRADERM, LLCSimilar federal contract value in Medtech · null in contracts
- SPIKE NEURO LLCSimilar federal contract value in Medtech · null in contracts
- BiobeatSimilar federal contract value in Medtech · null in contracts
- ELITE NEURO INCSimilar federal contract value in Medtech · null in contracts
- PETL FLUIDICS LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .